Trelegy Ellipta (Fluticasone furoate/Umeclidinium Bromide/Vilanterol Trifenatate)

Prescription Prescription Required     Customer Reviews
Trelegy Ellipta Brand
Dosage Quantity & Price
100/62.5/25mcg
200/62.5/25mcg
Fluticasone furoate/Umeclidinium Bromide/Vilanterol Trifenatate (Generic alternate to Trelegy Ellipta) Generic

We don't sell this generic-version medication.

  • We are Certified
  • Cipa Certified Canadian
  • Norton Shopping Guarantee
  • 5 Star Excellence award from Shopper Approved for collecting at least 100 5 star reviews
  • IPABC

Table of contents:

Trelegy Ellipta is a medication used as a once-daily maintenance treatment for Chronic Obstructive Pulmonary Disease (COPD) or asthma. It is a combination product that contains three active ingredients: fluticasone furoate, umeclidinium, and vilanterol. Fluticasone furoate is a corticosteroid, umeclidinium is an anticholinergic, and vilanterol is a long-acting beta2-adrenergic agonist. These three drugs work together by reducing inflammation, promoting bronchodilation, and keeping the airways open for better breathing.

Uses and Dosage

Trelegy Ellipta is an inhaler medication that patients use once daily inhaled into the mouth, as directed by a healthcare provider. Patients should refrain from opening the cover of the inhaler until they are ready to use it. Each time the inhaler's cover is opened, a dose of medication is prepared. Patients must avoid opening and closing the cover without inhaling the medication to not lose the dose. To avoid wasting medicine, refrain from closing the cover until after inhaling the medication. Patients may or may not sense the medication while inhaling. Patients should not exhale into the inhaler device.

Step-by-step direction on How to Use Trelegy Ellipta

  1. Peel the back lid of the inhaler packaging. Properly dispose of the desiccant that comes with it. Check the counter that indicates the number of doses each inhalation device contains. It should display “30” or “14” if it is a sample pack.
  2. Slide the cover of the inhaler downward. You will see the mouthpiece and hear a click. The number on the counter will go down by 1. This means that your inhaler is ready to use.
  3. Exhale fully and deeply.
  4. Put the inhaler’s mouthpiece into your mouth and seal your lips around it. Make sure that your hands or fingers are not blocking the air vent.
  5. Inhale steadily and deeply from the mouthpiece.
  6. Hold your breath for not less than 4 seconds and take the inhalation device away from your mouth.
  7. Breathe out slowly and close the inhaler by sliding the cover-up.
  8. Rinse your mouth with tap water and spit it out.

Side effect

Common Side Effects of Trelegy Ellipta:

  • Headache
  • Hoarseness/throat irritation
  • Change in taste
  • Cough
  • Back pain

Trelegy Ellipta Allergic Reactions:

  • Trouble breathing
  • Itching
  • Rashes
  • Hives
  • Swelling of the mouth or the entire face
  • Severe dizziness
  • Trouble sleeping

Serious Side Effects of Trelegy Ellipta:

  • Easy bruising
  • Bleeding
  • Tremors
  • White patches in the mouth
  • Increased thirst
  • Painful urination
  • Muscle weakness
  • Bone pain

Form and strength

Trelegy Ellipta is available in the following forms and strength:

Trelegy Ellipta: Inhalation Powder

  • 92/55/22 mcg
  • 100/62.5/25 mcg
  • 200/62.5/25 mcg

Caution

  • Before using trelegy, inform your doctor or pharmacist if you have any allergies, particularly to fluticasone, umeclidinium, or vilanterol. Moreover, it is vital to note that trelegy could contain inactive ingredients such as milk proteins, which might cause allergic reactions or other issues.
  • Trelegy ellipta should be used with caution in patients with cardiovascular disorders, especially coronary insufficiency, hypertension, and cardiac arrhythmias.
  • Trelegy contains fluticasone furoate, which is a corticosteroid. Patients with a history of hypersensitivity to corticosteroids should use trelegy with caution.
  • Drugs like fluticasone furoate (a component of trelegy ellipta) should be used with caution in patients with milk protein allergies, and milk protein allergy is contraindicated with trelegy ellipta.
  • Do not take trelegy ellipta with other medicines that contain a laba or an anticholinergic for any reason. Tell your healthcare provider about all your medical conditions and about all the medicines you take.

Frequently Asked Questions (FAQ)

Does Trelegy Ellipta cause breathing problems?

No, Trelegy Ellipta can actually help ease breathing problems in individuals with asthma or COPD.

Can I use Trelegy Ellipta if my breathing problems are worsening quickly?

If your breathing problems are worsening quickly, you should seek medical treatment.

How often should I use the Trelegy Ellipta inhaler?

The recommended dose of Trelegy Ellipta is one inhalation once daily.

Can I use Trelegy Ellipta for acute symptoms of COPD or asthma?

No, Trelegy Ellipta is not meant to provide quick relief for acute symptoms. It is a maintenance medication meant to be used once a day to manage chronic symptoms.

How long does it take Trelegy Ellipta to start working?

The time it takes for Trelegy Ellipta to start working varies from person to person. It may take a few days to a few weeks to experience the full benefits of the medication.

Resources

It's important to purchase Trelegy Ellipta from verified Canadian pharmacy.

Additional information

Generic name:

Fluticasone Furoate/Umeclidinium Bromide/Vilanterol Trifenatate, Fluticasone furoate/Umeclidinium Bromide/Vilanterol Trifenatate

Formulation:

Inhalation Powder

Strength(s):

100/62.5/25mcg, 200/62.5/25mcg

Quantities Available:

30 doses, 30doses, 60 doses, 90 doses

REVIEWS

Online Pharmacies Canada has provided information from third parties intended to increase awareness and does not contain all the information about Trelegy Ellipta (Fluticasone furoate/Umeclidinium Bromide/Vilanterol Trifenatate). Talk to your doctor or other qualified medical practitioners for medical attention or advice, or if you have any concerns about Trelegy Ellipta (Fluticasone furoate/Umeclidinium Bromide/Vilanterol Trifenatate).